Henry Rodriguez
PhD, MS, MBA
Bethesda, MD 20892, USA

About
Office Director of Cancer Clinical Proteomics Research
National Cancer Institute (NCI), National Institutes of Health (NIH)
Dr. Rodriguez has led the development of NCI’s clinical proteomic and proteogenomic research programs, which today includes the world’s largest public repository of proteogenomic sequence data and targeted fit-for-purpose assays. These efforts led to the formation of two Cancer Moonshot initiatives – the International Cancer Proteogenome Consortium (ICPC) and the Applied Proteogenomics OrganizationaL Learning and Outcomes (APOLLO) network, of which he developed and co-developed.
scientific
Projects
Craniopharyngioma, Medulloblastoma, HGG, (AT/RT), LGG, Ependymoma, Ganglioglioma, DNET, Schwannoma

Adam Resnick
Children’s Hospital of Philadelphia
Philadelphia, PA, USA
research